Sulbutiamine (e.q. Arcalion, Enerion, Sulbuxin)

  • Product Code: 127596

a synthetic derivative of thiamine (vitamin B1), composed of two modified thiamine molecules linked together. Its main distinguishing feature is its lipid solubility, which allows it to cross the blood-brain barrier more effectively than standard thiamine.

฿5,002.50 This special price only valid for web order
gram (minimum 0 gram)

Unit price will be cheaper for larger size

The price will be calculated based on the size you enter

  •  
piece(s), Packing Cost: 0/pcs

The product will be packed based on the requested quantity

  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -

What is Sulbutiamine?

Sulbutiamine is a synthetic derivative of thiamine (vitamin B1), composed of two modified thiamine molecules linked together. Its main distinguishing feature is its lipid solubility, which allows it to cross the blood-brain barrier more effectively than standard thiamine. It was first developed in Japan for treating thiamine deficiency (beriberi) and symptoms such as fatigue (asthenia). Today, it is available as a prescription medication (e.g., Arcalion) in some countries, and as an over-the-counter dietary supplement in others (e.g., the United States).


Potential Health Benefits and Research

Note: While some studies support its benefits, much of the research is older, limited in scope, or focused on specific patient populations. Large-scale trials in healthy individuals are lacking.


1. Asthenia (Fatigue and Weakness)

Claim: Sulbutiamine may reduce fatigue, especially chronic or post-infectious types.

Evidence:

  • Tiev K., Cabane J., Imbert J.C. (1999). Traitement de l'asthénie post-infectieuse par le sulbutiamine. Revue de médecine interne, 20(10), 912–918.
    → A double-blind, placebo-controlled study found Sulbutiamine significantly more effective than placebo in reducing post-infectious fatigue.

  • Shah S.N. (2003). Adjuvant role of vitamin B analogue (sulbutiamine) with anti-infective treatment in infection-associated asthenia. J Assoc Physicians India, 51, 891–895.
    → Suggests Sulbutiamine improved recovery from fatigue when combined with anti-infective treatment.

  • Bizot J.C. et al. (2005). Chronic treatment with sulbutiamine improves memory in an object recognition task.... Prog Neuro-Psychopharmacol Biol Psychiatry, 29(6), 928–935.
    → In rats, Sulbutiamine reduced behavioral inhibition—relevant to motivation and fatigue.


2. Memory and Cognitive Function

Claim: Often promoted as a nootropic for improving memory and focus.

Evidence:

  • Micheau J. et al. (1985). Chronic administration of sulbutiamine improves long term memory formation in mice. Pharmacol Biochem Behav, 23(2), 195–198.
    → Animal study suggests memory improvements, possibly via cholinergic modulation.

  • Ollat H. et al. (1998). Effects of sulbutiamine on psycho-behavioural inhibition in major depressive episodes. Encephale, 24(3), 209–214.
    → Found improvements in attention and cognitive processing speed.

  • Séverin P., Jean-Marie V. (2003). Effects of sulbutiamine on cognitive function... in patients with mild cognitive impairment. European Psychiatry, 18(Suppl 1), 123.
    → Abstract suggests potential benefit, though full data and replication are needed.

Overall: Evidence for cognitive enhancement in healthy individuals is anecdotal or animal-based. Human data are limited and mostly focused on clinical deficits (e.g., dementia, depression).


3. Mood and Psycho-Behavioral Inhibition

Claim: May reduce inhibition and improve mood in conditions like depression.

Evidence:

  • Lôo H. et al. (2000). Effects of sulbutiamine on psycho-behavioral inhibition in major depressive episodes. Prog Neuro-Psychopharmacol Biol Psychiatry, 24(1), 77–89.
    → Found significant improvements in emotional blunting, lack of drive, and physical retardation when used alongside antidepressants.


4. Erectile Dysfunction (Psychogenic Origin)

Claim: May help treat erectile dysfunction caused by psychological factors.

Evidence:

  • Dmitriev D.M., Gamidov V.V., Permiakova T.V. (2005). Clinical Efficacy of Arcalion in Treatment of Erectile Dysfunction. Urologiia, (4), 32–35.
    → A Russian study reported positive results, especially for psychogenic ED, though methodological concerns remain.


5. Thiamine Deficiency

Claim: Effective in treating thiamine deficiency (e.g., beriberi, Wernicke’s encephalopathy).

Evidence:

  • Sulbutiamine was originally created to address neurological and systemic consequences of deficiency, with better absorption and central nervous system (CNS) delivery than thiamine.

  • Standard thiamine remains effective for typical deficiency; Sulbutiamine may be more suitable in cases of malabsorption or CNS-specific need.




Be the first to review this product :-)

Please login to write a review.






Recommend Lab-Service
Lab Service Price
Sulbutiamine (e.q. Arcalion, Enerion, Sulbuxin)

a synthetic derivative of thiamine (vitamin B1), composed of two modified thiamine molecules linked together. Its main distinguishing feature is its lipid solubility, which allows it to cross the blood-brain barrier more effectively than standard thiamine.

What is Sulbutiamine?

Sulbutiamine is a synthetic derivative of thiamine (vitamin B1), composed of two modified thiamine molecules linked together. Its main distinguishing feature is its lipid solubility, which allows it to cross the blood-brain barrier more effectively than standard thiamine. It was first developed in Japan for treating thiamine deficiency (beriberi) and symptoms such as fatigue (asthenia). Today, it is available as a prescription medication (e.g., Arcalion) in some countries, and as an over-the-counter dietary supplement in others (e.g., the United States).


Potential Health Benefits and Research

Note: While some studies support its benefits, much of the research is older, limited in scope, or focused on specific patient populations. Large-scale trials in healthy individuals are lacking.


1. Asthenia (Fatigue and Weakness)

Claim: Sulbutiamine may reduce fatigue, especially chronic or post-infectious types.

Evidence:

  • Tiev K., Cabane J., Imbert J.C. (1999). Traitement de l'asthénie post-infectieuse par le sulbutiamine. Revue de médecine interne, 20(10), 912–918.
    → A double-blind, placebo-controlled study found Sulbutiamine significantly more effective than placebo in reducing post-infectious fatigue.

  • Shah S.N. (2003). Adjuvant role of vitamin B analogue (sulbutiamine) with anti-infective treatment in infection-associated asthenia. J Assoc Physicians India, 51, 891–895.
    → Suggests Sulbutiamine improved recovery from fatigue when combined with anti-infective treatment.

  • Bizot J.C. et al. (2005). Chronic treatment with sulbutiamine improves memory in an object recognition task.... Prog Neuro-Psychopharmacol Biol Psychiatry, 29(6), 928–935.
    → In rats, Sulbutiamine reduced behavioral inhibition—relevant to motivation and fatigue.


2. Memory and Cognitive Function

Claim: Often promoted as a nootropic for improving memory and focus.

Evidence:

  • Micheau J. et al. (1985). Chronic administration of sulbutiamine improves long term memory formation in mice. Pharmacol Biochem Behav, 23(2), 195–198.
    → Animal study suggests memory improvements, possibly via cholinergic modulation.

  • Ollat H. et al. (1998). Effects of sulbutiamine on psycho-behavioural inhibition in major depressive episodes. Encephale, 24(3), 209–214.
    → Found improvements in attention and cognitive processing speed.

  • Séverin P., Jean-Marie V. (2003). Effects of sulbutiamine on cognitive function... in patients with mild cognitive impairment. European Psychiatry, 18(Suppl 1), 123.
    → Abstract suggests potential benefit, though full data and replication are needed.

Overall: Evidence for cognitive enhancement in healthy individuals is anecdotal or animal-based. Human data are limited and mostly focused on clinical deficits (e.g., dementia, depression).


3. Mood and Psycho-Behavioral Inhibition

Claim: May reduce inhibition and improve mood in conditions like depression.

Evidence:

  • Lôo H. et al. (2000). Effects of sulbutiamine on psycho-behavioral inhibition in major depressive episodes. Prog Neuro-Psychopharmacol Biol Psychiatry, 24(1), 77–89.
    → Found significant improvements in emotional blunting, lack of drive, and physical retardation when used alongside antidepressants.


4. Erectile Dysfunction (Psychogenic Origin)

Claim: May help treat erectile dysfunction caused by psychological factors.

Evidence:

  • Dmitriev D.M., Gamidov V.V., Permiakova T.V. (2005). Clinical Efficacy of Arcalion in Treatment of Erectile Dysfunction. Urologiia, (4), 32–35.
    → A Russian study reported positive results, especially for psychogenic ED, though methodological concerns remain.


5. Thiamine Deficiency

Claim: Effective in treating thiamine deficiency (e.g., beriberi, Wernicke’s encephalopathy).

Evidence:

  • Sulbutiamine was originally created to address neurological and systemic consequences of deficiency, with better absorption and central nervous system (CNS) delivery than thiamine.

  • Standard thiamine remains effective for typical deficiency; Sulbutiamine may be more suitable in cases of malabsorption or CNS-specific need.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: ฿0.00
฿0.00 Total :